LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression
ME Montanez-Wiscovich, DD Seachrist, MD Landis, J Visvader, B Andersen, RA Keri
Oncogene | NATURE PUBLISHING GROUP | Published : 2009
Awarded by CURE
Awarded by NIH
We thank Jonathan Mosley for help with statistical analyses, Meredith Sorenson for technical support and members of the Keri laboratory, especially Gina Bernardo and Emhonta Johnson, for useful discussions. We are grateful for assistance from the Case Comprehensive Cancer Center core facilities (P30 CA43703). This work was supported by: RO1-CA090398 (RAK), CURE supplementary grant to RO1-CA090398 (RAK), NIH AR44882 (BA), T32-GM007250 (MEMW) and F31-CA123642 (MEMW).